v3.26.1
Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Income Statement [Abstract]      
Revenue $ 2,832 $ 699
Operating expenses:      
Cost of revenue (exclusive of depreciation and amortization below) 113   49
Research and development 17,348   10,009
General and administrative 9,759 12 1,912
Sales and marketing 1,401   228
Depreciation and amortization 1,617   1,277
Other operating income, net (4,139)   (11)
Total operating expenses 26,099 12 13,464
Loss from operations (23,267) (12) (12,765)
Other income (expense), net:      
Interest income (expense), net (190)   553
Gain on fair value of earn out share liabilities 2,833  
Other income, net 20   7
Total other income, net 2,663   560
Net loss (20,604) (12) (12,205)
Net comprehensive loss $ (20,821) $ (12) $ (12,142)
Net loss per share, basic (in Dollars per share) $ (0.28) [1] $ (12,035) $ (0.22) [1]
Net loss per share, diluted (in Dollars per share) $ (0.28) [1] $ (12,035) $ (0.22) [1]
Weighted average shares outstanding, basic (in Shares) 72,458,652 [1] 1 55,649,457 [1]
Weighted average shares outstanding, diluted (in Shares) 72,458,652 [1] 1 55,649,457 [1]
Comprehensive loss:      
Net loss $ (20,604) $ (12) $ (12,205)
Cumulative translation adjustment $ (217)   $ 63
[1] Net loss per share and weighted average shares outstanding have been retroactively recast after giving effect to the Reverse Recapitalization.